Canada's Bio-Revolution 2020 Webinar Series. "Editing our Economic Future: The Power of CRISPR”
September 28, 2020
A conversation between Gairdner Foundation laureates and leading Canadian researchers on using the opportunities and applications of gene editing, specifically by using CRISPR/Cas9, to transform multiple sectors, from therapeutics to diagnostics, agriculture, and low carbon manufacturing, all of which have a profound impact on our economy.
Government of Canada: Policy Statement on Research Security and COVID-19
September 14, 2020
The Government of Canada is encouraging all members of the research ecosystem to be aware of the potential risks to their work and asking them to take appropriate measures to protect their knowledge creation and innovations, all while maintaining a strong commitment to Open Science and support for a global research response to the COVID-19 pandemic.
Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus
Key members of the ONCoV Genomics Coalition, Samira Mubareka and Andrew McArthur conducted a collaborative study analyzing and predicting the recombination potential of SARS-CoV-2 and the Middle East respiratory syndrome coronavirus.
September 9, 2020
A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture
Three key members of the ONCoV Genomics Coalition, Bo Wang, Andrew McArthur, and Samira Mubareka conducted a study analyzing different genomic sequencing methods to understand which protocol works better for sequencing SARS-CoV-2.
August 17, 2020
ONCoV members funded through phase 2 of Ontario’s COVID-19 Rapid Research Fund
July 29, 2020
The Ontario Government announced phase two of funding for a number of research projects aimed at fighting COVID-19. The projects are a part of $20 million in funding that the Government has put towards the Ontario COVID-19 Rapid Research Fund, which focuses on research into “vaccine development, diagnostics, drug trials and development, and social sciences.”
Genetic detectives begin work to trace spread of COVID-19 in Canada
July 12, 2020
“Knowing how the virus spread will show where there were weaknesses in public health measures early on”, said Dr. Andrew McArthur, Director, biomedical discovery & commercialization at McMaster University and a key member of the ONCoV Genomics Coalition.
McMaster researcher traces spread of COVID-19 in Canada
July 12, 2020
One of the key members of the ONCoV Genomics Coalition Dr. Andrew McArthur, Director, biomedical discovery & commercialization at McMaster University is working on deducing how we tackled the COVID-19 pandemic and and what we can do to improve our response in future pandemics.
A simple protein-based SARS-CoV-2 surrogate neutralization assay
July 11, 2020
With the pandemic surpassing 12M confirmed cases & 550K deaths worldwide (by July 11, 2020), defining key components of immune response to SARS-CoV-2 is critical. Members of ONCoV Genomics Coalition Allison McGeer & Samira Mubareka are a part of the research team.
Genomics in the battle against COVID-19
June 1, 2020
Genomics plays an important role in COVID-19 research, from detecting infections and understanding how the virus mutates, to tracking these mutations and developing vaccines and treatments. Watch our two animated videos: On the Trail of Covid-19 & The Race for a Cure
Understanding a Disease – COVID-19 and Genomics Canada Podcast
June 1, 2020
COVID-19 is a virus that impacts different individuals in similar ways. In this podcast, Dr. Bettina Hamelin, President & CEO of Ontario Genomics and Dr. Rob Annan, President & CEO of Genome Canada explore the scientific aspects of COVID-19 dynamics and how it affects individuals.
Hospital News: Dr. Samira Mubareka - It’s all in the genome: Preparing for the next waves of COVID-19
May 28, 2020
On January 24th, Sunnybrook Health Sciences admitted the first Canadian patient with COVID-19. The traveller had just returned from Wuhan, China, the epicentre of the virus outbreak. He presented with a respiratory illness due to SARS-CoV-2, the coronavirus that causes COVID-19. At that moment I realized this virus would come to dominate our reality, both at Sunnybrook and across Canada.
COVID-19 Research: Genomics, Rapid Execution & Funding featuring Samira Mubareka
Ontario’s infectious disease expert speaks about her COVID-19 research in an interview with TheFuturEconomy.ca. Leading Sunnybrook’s Coronavirus response, her work on isolating & understanding the virus is helping roll out rapid research efforts.
April 27, 2020
Genome Canada leads $40 million genomics initiative to address COVID-19 pandemic
Important new pan-Canadian Genomics partnership with $40M investment – CanCOGeN, a multi-pronged national approach to harnessing robust genomic solutions to meet the COVID-19 challenge head-on.
April 23, 2020
Canadian bioscience firm says it’s approved for production of rapid COVID-19 testing device
Ontario-made rapid COVID-19 genomics technology from Spartan Bio received approval for frontline use. This quick and portable innovation significantly expands Canada’s testing capacity.
April 12, 2020
How Biotech is Changing the Way We Make Stuff
Dr. Bettina Hamelin, President & CEO, Ontario Genomics, discusses how increased federal funding for engineering biology could give Canada an edge on innovative manufacturing initiatives to spur economic recovery & create homegrown jobs.
September 24, 2020